Novacept was founded in 1995 to design, develop, manufacture and market innovative therapeutic devices to improve the quality of women's healthcare in a cost-effective manner.
Developed by Novacept, the NovaSure Impedance Controlled Endometrial Ablation System is a next generation medical device designed to reduce or eliminate excessive menstrual bleeding due to benign causes in pre-menopausal women who have completed childbearing.